Dicks, Lisa
Jakobs, Linda
Sari, Miriam
Hambitzer, Reinhard
Ludwig, Norbert
Simon, Marie-Christine
Stehle, Peter
Stoffel-Wagner, Birgit
Helfrich, Hans-Peter
Ahlborn, Jenny
Rühl, Martin
Hartmann, Bolette
Holst, Jens J.
Ellinger, Sabine http://orcid.org/0000-0002-9988-9406
Clinical trials referenced in this document:
Documents that mention this clinical trial
Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial
https://doi.org/10.1007/s00394-021-02674-1
Funding for this research was provided by:
Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (322-8.03.04.02-FH-STRUKTUR 2016/01)
Bundesministerium für Bildung und Forschung (FKZ 01EA1707)
Novo Nordisk Foundation Center for Basic Metabolic Research
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 24 April 2021
Accepted: 31 August 2021
First Online: 10 September 2021
Declarations
:
: The authors declare that they had no conflict of interest.
: This trial was performed according to the guidelines of the 1964 Declaration of Helsinki and its later amendments. The protocol was approved by the ethics committees of the University of Bonn, Germany (project ID 167/18, date of approval 25/06/2018), and of the Medical Association of North Rhine, Düsseldorf, Germany (project ID 2018254, date of approval 04/09/2018). All participants gave their written informed consent (including data publication) before enrollment.
: All participants gave their written informed consent before enrollment.
: All participants gave their written informed consent before enrollment.